Researchers found elevated blood levels of the RNA molecule Tu-Stroma in women with precancerous fallopian-tube lesions. The test detected 92.3% of affected women and correctly cleared 98.2% of healthy women; among genetically high-risk patients, negative results were nearly 100% accurate.